An Act To Expand Access To Lifesaving Opioid Overdose Medication
Sec. 1. 22 MRSA §2353, sub-§2, as enacted by PL 2013, c. 579, §1, is amended to read:
(1) The health care professional has an established health care professional-patient relationship with the individual; and
(2) The individual is at risk of experiencing an opioid-related drug overdose.
A health care professional who prescribes naloxone hydrochloride to a member of an individual's immediate family in accordance with this paragraph shall document in the individual's patient medical record the name of each family member who receives such a prescription and the health care professional's intention that the naloxone hydrochloride be administered to the individual.
Nothing in this subsection affects the provisions of law relating to maintaining the confidentiality of medical records.
Sec. 2. 22 MRSA §2353, sub-§4 is enacted to read:
Nothing in this subsection may be construed to bar the admissibility of any evidence obtained in connection with the investigation and prosecution of other crimes committed by a person who otherwise qualifies for limited immunity under this subsection.
This bill allows for the prescription of naloxone hydrochloride by standing order. It allows for the prescription of naloxone hydrochloride to friends of and other persons in a position to assist an individual at risk of experiencing an opioid-related drug overdose in addition to immediate family members. It provides for immunity from civil and criminal liability for the prescription and administration of naloxone hydrochloride for prescribers and those who administer the drug. It creates a limited immunity from criminal prosecution for those who seek medical assistance when a person is experiencing an opioid-related drug overdose.